Hasil Pencarian  ::  Simpan CSV :: Kembali

"Liposomes are used for drug carriers meaning that drugs are incorporated in the membrance or the vesicle of the liposomes. In this study, liposomes were prepared from mixed micelles, consisting of phosphatidylcholone, without or with cholesterol and sodium cholate was added in several ratios namely 0.44; 0.55; 0.63; 0.70; 0.90 and 1.10. After the preparation, the sodium cholate has been removed by a dialysis membrance, using the Hemoflow High Flux, which is generally used for haemodialysis. The Hemoflow High Flux is a tool an effort to obtain a simple, quick, effective method for removing sodium cholate in the process of preparing liposomes. The effectiveness of this tool was proved by the particle size of the liposome which was measured by the Malvern Particle Sizer. The particle size of the liposome consisting of phosphatidycholine (PC) without cholesterol and with cholesterol was 63-68 nm at all ratios andapproximately 125 nm at the ratio of 0.55; 0.63; 0.70, respectively. The particle size of the liposome tended to be smaller after dialyzing although the concentration of lipids tended to increase. However, a larger amount of buffer solution has to be used with this method."

"Liposom merupakan molekul pembawa yang tersusun dari lipid dalam bentuk vesikel sferis yang menjerap senyawa aktif ke dalamnya. Liposom telah banyak digunakan sebagai pembawa obat baik untuk pengobatan maupun pencegahan penyakit. Penelitian ini bertujuan untuk mengenkapsulasi meropenem ke dalam liposom unilamelar steril. Dua formula disiapkan, yakni formula 1 dengan komposisi lipid fosfatidilkolin dan kolesterol dengan perbandingan molar 5:5 dan formula 2 dengan fosfatidilkolin, kolesterol dan asam oleat dengan perbandingan molar 5:5:1. Liposom dibuat dengan metode hidrasi lapis tipis dilanjutkan dengan metode ekstrusi bertingkat menggunakan membran polikarbonat 0,45 μm dan 0,22 μm sebanyak 1 dan 5 siklus. Metode ini berhasil menghasilkan liposom unilamelar dengan rata-rata ukuran partikel 318 nm untuk formula 1 dan 213,9 nm untuk formula 2. Sterilisasi sediaan dilakukan dengan metode filtrasi menggunakan membran polikarbonat 0,22 μm. Selanjutnya, dilakukan pemurnian liposom dengan sentrifugasi aseptis. Namun, uji sterilitas sediaan menunjukkan bahwa sediaan tidak steril. Hal ini mungkin disebabkan karena proses pemurnian liposom yang dilakukan setelah sterilisasi. Efisiensi penjerapan berkurang seiring dengan peningkatan siklus ekstrusi bertingkat dan penambahan asam oleat. Efisiensi penjerapan liposom hasil hidrasi, ekstrusi 0,45 μm dan ekstrusi steril 0,22 μm secara berturut-turut ialah 102,2%, 90,7% dan 90,2% untuk formula 1 dan 60,2%, 45,3% dan 40,1% untuk formula 2.

---

Liposomes are carrier molecules composed of lipids in the form of spherical vesicles that encapsulate active compounds into it. Liposomes have been widely used as a drug carrier for the treatment or prevention of disease. This study aimed to encapsulate meropenem into sterile unilamellar liposome. Two formulations of meropenem-entrapped phosphatidylcholine : cholesterol (5:5) and phosphatidylcholine : cholesterol : oleic acid (5:5:1) were prepared by thin film hydration followed by stepwise extrusion. Liposomes were extruded once and then five times through 0.45 μm and 0.22 μm polycarbonate membrane pore size. This method is successful producing unilamellar liposomes with mean 318 nm particle size of formula 1 and 213.9 nm of formula 2. Liposomes were sterilized by filtration method using 0.22 μm polycarbonate membrane pore size and then purified by aseptic sentrifugation method. However, the sterility test showed that the liposome was not sterile. This result may be caused by the imperfection of purification method. The entrapment efficiency of meropenem in liposomes was decreasing along with addition of cycle of stepwise extrusion method and addition of oleic acid. The entrapment efficiency of hydrated, extruded through 0.45 μm pore size membrane and sterile extruded through 0.22 μm pore size membran liposomes in a row is 102.2%, 90.7% and 90.2% for formula 1 and 60.2%, 45.3% and 40.1% for formula 2."

"Liposom merupakan sistem pembawa obat yang dapat meningkatkan efektivitas penghantaran obat berbahan utama lipid agar mudah terpenetrasi dalam kulit. Ekstrak metanol kulit buah manggis (Garcinia mangostana L.) memiliki aktivitas antioksidan yang sangat tinggi terutama fraksi diklorometana. Fraksi diklorometana digunakan dalam formulasi liposom dan dibuat liposom triplo. Presipitat yang telah dipisahkan dari supernatan akan digunakan untuk membuat krim liposom 5%, 10%, dan 15%.Tujuan penelitian untuk menguji daya penetrasi α-Mangostin dalam krim liposom. Ketiga formulasi krim liposom dan krim fraksi diklorometana diuji daya penetrasinya secara in vitro dengan alat sel difusi Franz menggunakan membran abdomen tikus galur Sprague-Dawley. Jumlah kumulatif α-Mangostin yang terpenetrasi dari krim liposom 5%, 10%, 15% dan krim fraksi ialah 1,65 ± 2,22; 3,95 ± 0,13; 8,27 ± 0,14; dan 3,44 ± 0,27 μg/cm2. Presentase jumlah α-Mangostin yang terpenetrasi dari krim liposom 5%, 10%, 15% dan krim fraksi ialah 1,43 ± 1,92 %; 1,72 ± 0,06 %; 2,4 ± 0,04 %; dan 0,24 ± 0,02 %. Fluks dari krim liposom 5%, 10%, 15% dan krim fraksi ialah 0,058 ± 0,07; 0,088 ± 0,04; 0,349 ± 0,25; 0,22 ± 0,046 μg/cm2.jam.Berdasarkan hasil tersebut, dapat disimpulkan bahwa krim liposom 15% memiliki daya penetrasi terbaik bila dibandingkan dengan krim liposom 5%, krim liposom 10%. krim fraksi diklorometana yang dibuat menunjukkan kestabilan fisik. Uji aktivitas antioksidan dengan metode peredaman DPPH (2,2-Difenil-1-pikril hidrazil) dilakukan untuk mengetahui nilai IC50 dari krim liposom masing-masing konsentrasi. Aktivitas antioksidan terbaik pada sampel penetrasi SDF krim liposom 10% dengan nilai AEAC 187,861 ppm. Krim liposom telah yang telah diuji menunjukkan stabilitas fisik pada berbagai suhu penyimpanan, uji mekanik dan cycling test.

---

Liposome is a drug carrier system that can enhance the effectiveness of drug delivery which is made from the lipid that easily penetrated into the skin. The methanol extract of mangosteen pericarp (Garcinia mangostana L.) has been proved rich in xanthone compounds that have very high potential of antioxidant activity, especially the fractionation of dichloromethane (FD). The aim of this study to test the penetration ability of liposomal cream throughout mouse's skin. The FD has been used in making liposome as triploid. The precipitate of liposome with the best entrapment efficiency of liposome (77,09%) is used in making liposomal cream (LC) with 5%, 10% and 15% concentration.The liposome had been made as triploid and the precipitate of the liposome with the best entrapment efficiency will be used in LC. The three dosage forms and FD cream was examined their physical stability and penetration ability by in vitro Franz Diffusion Cell test using Sprague-Dawley rat abdomen skin as diffusion membrane. Total cumulative penetration of α-mangostin from 5%, 10% and 15% (LC) and FDC were 1,65 ± 2,22; 3,95 ± 0,13; 8,27 ± 0,14; and 3,44 ± 0,27 μg/cm2. The percentage of penetrated α-mangostin from 5%, 10% and 15% LCs and DFC were 1,43 ± 1,92 %; 1,72 ± 0,06 %; 2,4 ± 0,04 %; dan 0,24 ± 0,02 % respectively. Flux of α-mangostin from 5%, 10% and 15% LCs and DFC were 0,058 ± 0,07; 0,088 ± 0,04; 0,349 ± 0,25; 0,22 ± 0,046 μg/cm2hour, respectively.Penetration ability of 15% LC is higher than FDC, 5% and 10% LCs. The method was used in this study the reduction of DPPH (2,2-Diphenyl-1-pikril hidrazil) to determine the IC50 value of LC. IC50 values of the FD was 17.47 ppm. The best antioxidant activity with AEAC value 187.861 ppm is penetration sample of 10% LC."

"Pemanfaatan mikrosfer sebagai agen penghantar obat telah banyak dikembangkan. Polipaduan PLLA dan PCL digunakan sebagai bahan dasar pembuatan mikrosfer untuk meningkatkan kemampuan permeabilitas dan laju degradasi dari mikrosfer. Pada penelitian ini mikrosfer polipaduan dibuat dengan memvariasikan konsentrasi surfaktan, kecepatan pengadukan dispersi, dan waktu pengadukan dispersi untuk melihat pengaruhnya terhadap bentuk fisik mikrosfer, persen padatan mikrosfer yang diperoleh, serta ukuran dan keseragaman dari mikrosfer. Mikrosfer yang diperoleh dikarakterisasi dengan FT IR, PSA, dan Mikroskop Stereo. Hasil penelitian menunjukkan bahwa semakin besar konsentrasi surfaktan yang digunakan menghasilkan ukuran mikrosfer yang semakin kecil. Pada variasi kecepatan pengadukan, jika kecepatan pengadukan ditingkatkan diperoleh ukuran mikrosfer yang semakin kecil, namun setelah melewati kondisi optimum kecepatan yang terlampau tinggi mengakibatkan ukuran kembali besar karena meningkatkan kemungkinan mikrosfer yang belum padat untuk bertemu dan menyatu kembali Untuk variasi waktu pengadukan dispersi diperoleh waktu pengadukan paling baik yaitu 1 jam karena menghasilkan mikrosfer dengan ukuran terkecil dan keseragaman yang baik.

---

The use of microspheres as drug delivery agents has been widely developed. Polyblend is used as the base material for making microspheres to increase permeability and degradation rates of the microspheres. In this study, the polyblend microspheres were made by varying the surfactant concentration, the dispersion stirring speed, and the time of dispersion stirring to see the effect on the physical shape of the microspheres, the percentage of solid microspheres obtained, the size and uniformity of the microspheres. The microspheres obtained were characterized by FT IR, PSA, and Stereo Microscope.

The results show that the smaller the concentration of surfactants used will result in smaller sizes of microspheres. At variations in stirring speed, if the stirring speed is increased, the smaller the size of the microspheres will be. But after passing the optimum speed, the size of the microspheres will be enlarged again because it increases the possibility of the microspheres that have not been solid to reunite. For variations in the time of dispersion, the best stirring time is obtained 1 hour because it produces microspheres with small size and good uniformity."

"Sebagai suatu pembawa obat (drug carrier), liposom dapat mengubah farmakokinetik obat yang dibawanya, sehingga obat dapat bekerja langsung pada target sasaran sedangkan efek sampingnya akan berkurang. Untuk menjadi pembawa obat yang baik, liposom harus memenuhi persyaratan mutlak yaitu stabil secara kimia, fisika dan biologi. Salah satu faktor yang mempengaruhi kestabilan liposom adalah komposisi penyusunnya, antara lain yang sedang dikembangkan saat ini adalah liposom EPC-TEL 2,5. Liposom EPC-TEL 2,5 tersusun atas Fosfatidilkolin kuning telur (egg-yolk Phosphatidylcholine=EPC) dan Tetraeter lipid (TEL) yang berasal dari bakteri Thermoplasma acidofilum. Dalam penelitian ini akan dilakukan uji stabilitas kimia berupa penambahan garam NaCl 150 mOsmol pH 7 pada liposom EPC-TEL 2,5 yang telah disonikasi selama 60 menit. Penambahan jumlah liposom berukuran lebih dari 100 nm, menjadi indikator perubahan stabilitas liposom pada penelitian ini. Hasil dan Kesimpulan: Tidak terdapat penambahan jumlah liposom yang berukuran lebih dari 100 nm secara bermakna setelah penambahan garam NaCl 150 mOsmol pH 7 dibandingkan kontrol.

---

As a drugs carrier, liposome can alter the pharmacokinetics of the entrapped drugs. Thus, drugs can act directly on the targeted cell while their systemic side effects are reduced. To become an effective drugs carrier, liposome must reach its stability in chemical, physical, and biological conditions. Liposome stability can be achieved by changing the lipid composition, such as EPC-TEL 2,5 which is made from the combination of Egg Yolk Phosphatydyl Coline (EPC) and TEL 2,5 mol % that is extracted from Thermoplasma acidofilum. The aim of this study is to test the chemical stability of liposome EPC-TEL 2,5 with sonication by addition of NaCl 150 mOsmol pH 7 solution. The increase in number of liposome larger than 100 nm is the stability parameter in this study. After observation at day 0, 7, 30, 60, 90, there was no significant increase in the number of liposome larger than 100 nm after addition of NaCl 150 mOsmol pH 7 compared with control."

"Liposom merupakan suatu sistem pembawa obat berbentuk vesikel yang dapat mengenkapsulasi siprofloksasin HCl dan berpotensi untuk memgatasi infeksi yang disebabkan oleh bakteri Multidrug Resistance Pseudomonas aeruginosa. Tujuan penelitian ini adalah membuat liposom siprofloksasin HCl unilamellar yang steril dengan metode sterilisasi filtrasi. Metode hidrasi lapis tipis yang digunakan akan menghasilkan liposom Multilamellar Vesicle (MLV). Liposom MLV yang dihasilkan dilakukan pengecilan ukuran partikel secara ekstrusi melewati membran polikarbonat 0,45 μm sebanyak 1 siklus dan disterilisasi secara filtrasi dengan membran selulosa asetat 0,22 μm sebanyak 5 siklus untuk mendapatkan liposom unilamellar yang kecil. Suspensi liposom steril yang didapat kemudian dipisahkan secara sentrifugasi dandiuji sterilitasnya pada medium tioglikolat cair dan plat agar darah. Efisiensi penjerapan liposom menurun seiring dengan proses ekstrusi melewati membran 0,45 μm dan 0,22 μm dimana mengalami penurunan efisiensi penjerapan berturut-turut sebesar 71,46%, 33,94%, 30,37% pada liposom formula I dan liposom formula II sebesar 90,96%, 44,83%, 36,11%. Proses ekstrusi dengan membran 0,45 μm dan 0,22 μm dapat menghasilkan ukuran liposom yang kecil, namun belum dapat menyerupai ukuran pori membran. Selain itu, penambahan asam oleat cenderung meningkatkan ukuran diameter liposom. Liposom siprofloksasin HCl yang dihasilkan terbukti tidak steril setelah diujikan pada medium tioglikolat cair dan plat agar darah.

---

Liposome is a vesicular drug delivery system that able to encapsulate ciprofloxacin HCl, and have potential to cure an infection that caused by Multi Drug Resistance Pseudomonas aeruginosa bacteria. This study aimed to produce sterile and unilamellar ciprofloxacin HCl liposome usingfiltration sterilization method. Thin-film hydration method will be use to produce Multilamellar Liposome Vesicle (MLV). Later, the MLV liposome, will going through a particle size reduction using extrusion method through polycarbonate membrane (pore size 0.45 μm) for 1 cycle and being sterilized by filtration through cellulose acetate membrane (pore size 0.22 μm) for five cycles to get the small unilamellar liposome. The sterile liposome suspension is separated using centrifugation method and its sterilities will be test on medium thioglychollate fluid and blood agar plate. The entrapment efficiency of liposome decrease along the extrusion process through 0.45 μm and 0.22 μm membrane, of which the entrapment efficiency decreased respectively by 71.46%, 33.94%, 30.37% for formula I and 90.96%, 44.83%, 36.11% for formula II. The extrusion process through 0.45 μm and 0.22 μm membrane can produce the small size liposome, but still can not reach the average diameter of membrane pore size. Moreover, mostly the addition of oleic acid will increase the diameter size of liposome. Ciprofloxacin HCl liposome is proved to be unsterile according to the sterility test in fluid thioglycollate medium and blood agar plate."

"This study is proposed to solve the main problem in the first experiment which has the pitfall of the incorporation of methylprednisolone (MPL) into liposome's membrane. The liposomal-methylprednisolone (L-MPL) has already been formulated by Mishina, et at31.32 and experimented on several studies of organ transplantation in rat, successfully. But, all procedures even using other combination and ratio of lipids are irreproducible methods. The pitfall of the incorporation of MPL into liposome's membrane is caused by the micelle formation of MPL.To reduce or may be to inhibit the micelle formation of MPL that usually formed spontaneously when it is dispersed in aqueous media, the reactive -OH group at C21 position should have been esterified with palmitate to enhance the lipophilicity of the drug. This reaction, based on the Benameur's method, yielded 71% of pure methylprednisolonepalmitate (MPLP) as a new drug. To analyze the properties of this drug such as the stability or the availability of the drug both in liposome's membrane and in several organs in vivo, several studies have already been done in this study using sophisticated equipment.The incorporation of the new drug , MPLP, into liposome's membrane of a conventional liposome of Egg-yolk Phosphatidylcholine (EPC) was 70 %_ The incorporation was increased to approximately 95 % in liposome's membrane of EPC and tetra ether lipids (TEL) from Sulfolobus acidocaldarius as a stabilizer of the liposomal membrane The newest drug that is proposed in evaluating the stability of the drug in vitro and the distribution of the drug on several organs in mice is liposomal- methylprednisolone-palmitate (L-MPLP).The stability of L-MPLP in vitro was evaluated on their particle size. They were more stable at 20° C for 9 days of incubation than at room temperature. In vivo study of L-MPLP were shown as a distribution of the metabolite of MPL or MPLP on several organs on TLC where the distribution in the liver has more higher than in the spleen, kidney, thymus, and bone-marrow, in sequence. The distribution of the metabolite of L-MPLP in the liver has also shown higher than the metabolite of the control group of liposome, MPL, or MPLP as a free drug.Because of these successful results, this experiment will have to be continued to improve the stability of this drug and to analyze the other effects on immunosuppressive properties, toxicity, pharmacokinetics and pharmacodynamics of the drug."